Chemical Structure : SB-525334
CAS No.: 356559-20-1
Catalog No.: PC-42858Not For Human Use, Lab Use Only.
SB-525334 is a potent and selective inhibitor of TGF-β1 receptor (ALK5) inhibitor with IC50 of 14,5 nM, 4-fold less potent against ALK4 and inactive for ALK2, ALK3, and ALK6 (IC50>10 uM).
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $78 | In stock | |
25 mg | $138 | In stock | |
50 mg | $218 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
SB-525334 is a potent and selective inhibitor of TGF-β1 receptor (ALK5) inhibitor with IC50 of 14,5 nM, 4-fold less potent against ALK4 and inactive for ALK2, ALK3, and ALK6 (IC50>10 uM).
SB 525334 blocks TGFβ1-induced phosphorylation and nuclear translocation of Smad2/3 in renal proximal tubule cells and inhibits TGFβ1-induced increases in PAI-1 and procollagen α1 mRNA expression in A498 renal epithelial carcinoma cells at 1 uM.
SB 525334 significantly inhibits PAN-induced proteinuria in rat model of nephritis-induced renal fibrosis.
M.Wt | 343.4249 | |
Formula | C21H21N5 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
DMSO: ≥ 46 mg/mL |
|
Chemical Name/SMILES |
Quinoxaline, 6-[2-(1,1-dimethylethyl)-5-(6-methyl-2-pyridinyl)-1H-imidazol-4-yl]- |
1. Grygielko ET, et al. J Pharmacol Exp Ther. 2005 Jun;313(3):943-51.
2. Laping NJ, et al. Clin Cancer Res. 2007 May 15;13(10):3087-99.
3. Thomas M, et al. Am J Pathol. 2009 Feb;174(2):380-9.
4. Kim YJ, et al. Anticancer Res. 2012 Mar;32(3):799-806.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright